JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

Workday (NASDAQ:WDAY – Get Free Report)‘s stock had its “market outperform” rating reiterated by research analysts at JMP ...

JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...

Enova International (NYSE:ENVA – Free Report) had its target price upped by JMP Securities from $125.00 to $135.00 in a ...

JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

Wall Street analysts rerated Cloudflare, Inc (NYSE:NET) after the company released its fourth-quarterly print Thursday.

周五，JMP Securities重申了对Sprinklr Inc (NYSE: CXM )的"市场跑赢"评级，维持目标价17.00美元不变。该公司分析师强调了公司当前的业绩表现，包括第三财季8%的增长和12%的营业利润率。公司展现出稳健的基本面，过去十二个月毛利率达73.29%，营收为7.8806亿美元。根据 InvestingPro ...

周五，JMP Securities分析师将Cloudflare Inc. (NYSE: NET )的股票目标价从此前的135美元上调至180美元，同时维持"市场表现优于大盘"评级。这一调整反映了该机构对公司在网络安全领域独特地位的持续信心。根据 InvestingPro ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...